Friday, 14 March 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 14 March 2025
News

Worst off-label offenders targeted

Posted 14 March 2025 AM

The Federal Government has made another bid to lower the off-label prescribing of Novo Nordisk's Ozempic to treat obesity, with a targeted letter campaign to the worst offenders.

The Department of Health and Aged Care has written to the top 10 per cent of doctors writing PBS scripts for patients without any identifiable history of type 2 diabetes, reminding them of the PBS criteria for prescribing Ozempic, and that no off-label prescribing is PBS funded, reports AusDoc.

To see the whole article, please login

Popular

Where HCPs are feeling fresh pain
Drug safety alert extended to men
Drug racing to $1 billion on PBS
Worst off-label offenders targeted
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (37)

Clinical & Medical, R&D (14)

Regulatory, Pharmacovigilance & QA (1)

Other (19)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home